Neurofibromin
Das NF1-Gen kodiert ein Portein welches an der Signaltransduktion beteiligt ist. Es ist ein negativer Regulator des intrazellulären ras-Weges. Mutationen führen zu autosomal dominanten Erkrankungen wie Neurofibromatose 1, Watson-Syndrom und juveniler myelomonozytärer Leukämie. Letztere wird auch bei somatischen Mutationen gesehen.
Gentests:
Klinisch |
Untersuchungsmethoden |
Familienuntersuchung |
Bearbeitungszeit |
5 Tage |
Probentyp |
genomische DNS |
Verknüpfte Erkrankungen:
Referenzen:
1. |
Mukhopadhyay D et. al. (2002) C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme.
[^]
|
2. |
Wallace MR et. al. (1991) A de novo Alu insertion results in neurofibromatosis type 1.
[^]
|
3. |
Weiming X et. al. (1992) Molecular analysis of neurofibromatosis type 1 mutations.
[^]
|
4. |
Upadhyaya M et. al. (1992) Analysis of mutations at the neurofibromatosis 1 (NF1) locus.
[^]
|
5. |
Stark M et. al. (1992) Analysis of segregation and expression of an identified mutation at the neurofibromatosis type 1 locus.
[^]
|
6. |
Legius E et. al. (1992) NF1-related locus on chromosome 15.
[^]
|
7. |
Daston MM et. al. (1992) The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes.
[^]
|
8. |
DeClue JE et. al. (1992) Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis.
[^]
|
9. |
Li Y et. al. (1992) Somatic mutations in the neurofibromatosis 1 gene in human tumors.
[^]
|
10. |
Basu TN et. al. (1992) Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients.
[^]
|
11. |
Xu G et. al. (1992) Characterization of human adenylate kinase 3 (AK3) cDNA and mapping of the AK3 pseudogene to an intron of the NF1 gene.
[^]
|
12. |
Viskochil D et. al. (1990) Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus.
[^]
|
13. |
Pulst SM et. al. (1991) Familial spinal neurofibromatosis: clinical and DNA linkage analysis.
[^]
|
14. |
Estivill X et. al. (1991) Recurrence of a nonsense mutation in the NF1 gene causing classical neurofibromatosis type 1.
[^]
|
15. |
Allanson JE et. al. (1991) Watson syndrome: is it a subtype of type 1 neurofibromatosis?
[^]
|
16. |
Marchuk DA et. al. (1991) cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product.
[^]
|
17. |
Stark M et. al. (1991) A small deletion and an adjacent base exchange in a potential stem-loop region of the neurofibromatosis 1 gene.
[^]
|
18. |
Gutmann DH et. al. (1991) Identification of the neurofibromatosis type 1 gene product.
[^]
|
19. |
DeClue JE et. al. (1991) Identification and characterization of the neurofibromatosis type 1 protein product.
[^]
|
20. |
Xu GF et. al. (1990) The neurofibromatosis type 1 gene encodes a protein related to GAP.
[^]
|
21. |
Upadhyaya M et. al. (1990) A 90 kb DNA deletion associated with neurofibromatosis type 1.
[^]
|
22. |
Wallace MR et. al. (1990) Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients.
[^]
|
23. |
Buchberg AM et. al. (1990) Sequence homology shared by neurofibromatosis type-1 gene and IRA-1 and IRA-2 negative regulators of the RAS cyclic AMP pathway.
[^]
|
24. |
Allanson JE et. al. (1985) Noonan phenotype associated with neurofibromatosis.
[^]
|
25. |
Huson SM et. al. (1989) A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity.
[^]
|
26. |
Barker D et. al. (1987) Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17.
[^]
|
27. |
Hull J et. al. (1994) The stop mutation R553X in the CFTR gene results in exon skipping.
[^]
|
28. |
Purandare SM et. al. (1995) Characterisation of a novel splice donor mutation affecting position +1 in intron 18 of the NF-1 gene.
[^]
|
29. |
Lázaro C et. al. (1995) Two further cases of mutation R1947X in the NF1 gene: screening for a relatively common recurrent mutation.
[^]
|
30. |
Vogel KS et. al. (1995) Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons.
[^]
|
31. |
Li Y et. al. (1995) Genomic organization of the neurofibromatosis 1 gene (NF1).
[^]
|
32. |
Heim RA et. al. (1994) Screening for truncated NF1 proteins.
[^]
|
33. |
Horiuchi T et. al. (1994) Nonsense mutations at Arg-1947 in two cases of familial neurofibromatosis type 1 in Japanese.
[^]
|
34. |
Valero MC et. al. (1994) Characterization of four mutations in the neurofibromatosis type 1 gene by denaturing gradient gel electrophoresis (DGGE).
[^]
|
35. |
Tassabehji M et. al. (1993) Tandem duplication within a neurofibromatosis type 1 (NF1) gene exon in a family with features of Watson syndrome and Noonan syndrome.
[^]
|
36. |
Nakafuku M et. al. (1993) Suppression of oncogenic Ras by mutant neurofibromatosis type 1 genes with single amino acid substitutions.
[^]
|
37. |
Ainsworth PJ et. al. (1993) Identification and characterization of sporadic and inherited mutations in exon 31 of the neurofibromatosis (NF1) gene.
[^]
|
38. |
Dietz HC et. al. (1993) The skipping of constitutive exons in vivo induced by nonsense mutations.
[^]
|
39. |
Johnson MR et. al. (1993) Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulation of GTP.Ras.
[^]
|
40. |
Skuse GR et. al. (1996) The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing.
[^]
|
41. |
Robinson PN et. al. (1996) Recurrent 2-bp deletion in exon 10c of the NF1 gene in two cases of von Recklinghausen neurofibromatosis.
[^]
|
42. |
Colley A et. al. (1996) Neurofibromatosis/Noonan phenotype: a variable feature of type 1 neurofibromatosis.
[^]
|
43. |
Wu R et. al. (1996) Neurofibromatosis type I gene mutation in a patient with features of LEOPARD syndrome.
[^]
|
44. |
Upadhyaya M et. al. (1997) Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene.
[^]
|
45. |
Cappione AJ et. al. (1997) A potential role for NF1 mRNA editing in the pathogenesis of NF1 tumors.
[^]
|
46. |
Silva AJ et. al. (1997) A mouse model for the learning and memory deficits associated with neurofibromatosis type I.
[^]
|
47. |
The I et. al. (1997) Rescue of a Drosophila NF1 mutant phenotype by protein kinase A.
[^]
|
48. |
Guo HF et. al. (1997) Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides.
[^]
|
49. |
Poyhonen M et. al. (1997) Hereditary spinal neurofibromatosis: a rare form of NF1?
[^]
|
50. |
Maynard J et. al. (1997) Characterization and significance of nine novel mutations in exon 16 of the neurofibromatosis type 1 (NF1) gene.
[^]
|
51. |
Side L et. al. (1997) Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders.
[^]
|
52. |
Abernathy CR et. al. (1997) NF1 mutation analysis using a combined heteroduplex/SSCP approach.
[^]
|
53. |
Gutmann DH et. al. (1997) The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.
[^]
|
54. |
Skuse GR et. al. (1997) RNA processing and clinical variability in neurofibromatosis type I (NF1).
[^]
|
55. |
Hoffmeyer S et. al. (1998) Nearby stop codons in exons of the neurofibromatosis type 1 gene are disparate splice effectors.
[^]
|
56. |
Ars E et. al. (1998) A clinical variant of neurofibromatosis type 1: familial spinal neurofibromatosis with a frameshift mutation in the NF1 gene.
[^]
|
57. |
Side LE et. al. (1998) Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1.
[^]
|
58. |
Klose A et. al. (1998) Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1.
[^]
|
59. |
Kluwe L et. al. (1999) Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas.
[^]
|
60. |
Osborn MJ et. al. (1999) Evaluation of the protein truncation test and mutation detection in the NF1 gene: mutational analysis of 15 known and 40 unknown mutations.
[^]
|
61. |
Faravelli F et. al. (1999) Unusual clustering of brain tumours in a family with NF1 and variable expression of cutaneous features.
[^]
|
62. |
Ars E et. al. (2000) Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1.
[^]
|
63. |
Eisenbarth I et. al. (2000) Toward a survey of somatic mutation of the NF1 gene in benign neurofibromas of patients with neurofibromatosis type 1.
[^]
|
64. |
Fahsold R et. al. (2000) Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain.
[^]
|
65. |
Park KC et. al. (2000) A nonsense mutation at Arg-1947 in the NF1 gene in a case of neurofibromatosis type 1 in a Korean patient.
[^]
|
66. |
Messiaen LM et. al. (2000) Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects.
[^]
|
67. |
Gutzmer R et. al. (2000) Allelic loss at the neurofibromatosis type 1 (NF1) gene locus is frequent in desmoplastic neurotropic melanoma.
[^]
|
68. |
Liu HX et. al. (2001) A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes.
[^]
|
69. |
None (2001) The neurofibromatoses: when less is more.
[^]
|
70. |
Messiaen LM et. al. () Exon 10b of the NF1 gene represents a mutational hotspot and harbors a recurrent missense mutation Y489C associated with aberrant splicing.
[^]
|
71. |
Luijten M et. al. (2001) Duplication and transposition of the NF1 pseudogene regions on chromosomes 2, 14, and 22.
[^]
|
72. |
Kaufmann D et. al. (2001) Spinal neurofibromatosis without café-au-lait macules in two families with null mutations of the NF1 gene.
[^]
|
73. |
Weeber EJ et. al. (2002) Molecular neurobiology of human cognition.
[^]
|
74. |
Gervasini C et. al. (2002) Tandem duplication of the NF1 gene detected by high-resolution FISH in the 17q11.2 region.
[^]
|
75. |
Cartegni L et. al. (2002) Listening to silence and understanding nonsense: exonic mutations that affect splicing.
[^]
|
76. |
Fairbrother WG et. al. (2002) Predictive identification of exonic splicing enhancers in human genes.
[^]
|
77. |
Kehrer-Sawatzki H et. al. (2002) Molecular characterisation of t(17;22)(q11.2;q11.2) is not consistent with NF1 gene duplication.
[^]
|
78. |
Maris JM et. al. (2002) Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13.
[^]
|
79. |
Upadhyaya M et. al. (2003) Three different pathological lesions in the NF1 gene originating de novo in a family with neurofibromatosis type 1.
[^]
|
80. |
Ruiz-Lozano P et. al. (2003) Cre-constructing the heart.
[^]
|
81. |
Messiaen L et. al. (2003) Independent NF1 mutations in two large families with spinal neurofibromatosis.
[^]
|
82. |
Kehrer-Sawatzki H et. al. (2003) Interphase FISH, the structure of reciprocal translocation chromosomes and physical mapping studies rule out the duplication of the NF1 gene at 17q11.2. A reply.
[^]
|
83. |
Baralle D et. al. (2003) Different mutations in the NF1 gene are associated with Neurofibromatosis-Noonan syndrome (NFNS).
[^]
|
84. |
Kluwe L et. al. (2003) NF1 mutations and clinical spectrum in patients with spinal neurofibromas.
[^]
|
85. |
Colapietro P et. al. (2003) NF1 exon 7 skipping and sequence alterations in exonic splice enhancers (ESEs) in a neurofibromatosis 1 patient.
[^]
|
86. |
Castle B et. al. (2003) Evaluation of genotype-phenotype correlations in neurofibromatosis type 1.
[^]
|
87. |
Wiest V et. al. (2003) Somatic NF1 mutation spectra in a family with neurofibromatosis type 1: toward a theory of genetic modifiers.
[^]
|
88. |
Mosse YP et. al. (2004) Germline PHOX2B mutation in hereditary neuroblastoma.
[^]
|
89. |
Ferner RE et. al. (2004) Neurofibromatous neuropathy in neurofibromatosis 1 (NF1).
[^]
|
90. |
Zatkova A et. al. (2004) Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1.
[^]
|
91. |
Ragge NK et. al. (2005) Heterozygous mutations of OTX2 cause severe ocular malformations.
[^]
|
92. |
Bertola DR et. al. (2005) Neurofibromatosis-Noonan syndrome: molecular evidence of the concurrence of both disorders in a patient.
[^]
|
93. |
De Luca A et. al. (2005) NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome.
[^]
|
94. |
Stevenson DA et. al. (2006) Clinical and molecular aspects of an informative family with neurofibromatosis type 1 and Noonan phenotype.
[^]
|
95. |
Ling JQ et. al. (2006) CTCF mediates interchromosomal colocalization between Igf2/H19 and Wsb1/Nf1.
[^]
|
96. |
Trovó-Marqui AB et. al. (2006) Neurofibromin: a general outlook.
[^]
|
97. |
Upadhyaya M et. al. (2007) An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation.
[^]
|
98. |
Kolanczyk M et. al. (2007) Multiple roles for neurofibromin in skeletal development and growth.
[^]
|
99. |
Henderson RA et. al. (2007) Inherited PAX6, NF1 and OTX2 mutations in a child with microphthalmia and aniridia.
[^]
|
100. |
None (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways.
[^]
|
101. |
Sabbagh A et. al. (2009) Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1.
[^]
|
102. |
Thiel C et. al. (2009) Independent NF1 and PTPN11 mutations in a family with neurofibromatosis-Noonan syndrome.
[^]
|
103. |
Nyström AM et. al. (2009) Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1.
[^]
|
104. |
Phan VT et. al. (2010) The RasGAP proteins Ira2 and neurofibromin are negatively regulated by Gpb1 in yeast and ETEA in humans.
[^]
|
105. |
Lubeck BA et. al. (2015) Cutting Edge: Codeletion of the Ras GTPase-Activating Proteins (RasGAPs) Neurofibromin 1 and p120 RasGAP in T Cells Results in the Development of T Cell Acute Lymphoblastic Leukemia.
[^]
|
Update: 26. September 2018